HIVEC is next big step to prevent recurrence in superficial bladder cancer

Cancerous tumours in the genito-urinary system are amongst the most common type of cancers occurring in patients diagnosed with the life-threatening disease. According to studies in recent years, genito-urinary cancers are common amongst Indian males and females, accounting for nearly 21 per cent of all cases. In males, 30.4 per cent of genitourinary system malignancies (17.50 per cent) consisted of urinary bladder malignancies. At a global scale, of 356,000 new cases of urinary bladder cancer diagnosed annually, the disease results in the death of 145,000 patients.
 
Currently, bladder cancer in India is treated with Bacillus Calmette-Guerin (BCG) intravesical immunotherapy.